Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
22 April (approx)
Oh dear, oh dear.
GoSushi, name me a company, successful or otherwise, where "adverse and unexpected events have [NOT] happened in the history of the company."
Wyndrum knows diddly-squat about the pharma industry, just as he knows the square root of f'all about helium mining, ship building or whatever other industry he's gambled in. So do you really think his talking points are worth anything?
"The comments below the article are very sad"
A mixture of ignorance and agenda, mainly from people in the USA, such as "There is no money to be made in curing cancer. The money is in high dollar chemo treatments, which produce their own various side effects, which generate additional revenue." Talk about putting the cart before the horse!!!
A sensible (realistic) comment from the 'Welsh border, United Kingdom,1 day ago' "That's what chemo does. It's horrific. It's not a miracle cure, it keeps you going for longer than you would of had if you can put up with what it does to your body."
Wyndrum is a troll. A very tedious troll. Just ignore, fiter or report.
"They might just be covering their IP bases without planning to develop yet."
The IP life starts ticking as soon as the patent is filed. You either patent to protect something you're putting into development or you patent to queer the pitch for others who may want to patent in that area (by publishing prior art to negate the novelty) - or you patent because a competitor is, or may be, about to patent.
Yeah but Thompi, that was before AS got his speeding ticket.
Another special kind of idiot. If you're going to try your hand at FUD at least do SOME research.
Poster presentation is on 9 April.
Congratulations 5RINGS, you have demonstratd the art of stupidity in spuds with added neediness. Well done you. Maybe ask your carer nicely if SHE will ask for a shareholder tour for you if you can't overcome your natural reticence.
Apparently he was clutching a share certificate and demanding at the top of his voice that he be allowed in to see how they make the food.
You really are a tedious twat Eggy.
5RINGS, are you innately stupid or did it take practice?
Do you think CC organised and executed this independently of the GCD? Busy lady. What else could she take on?
@Thornogson's "Just like the ease that they we're able to modify the Affimers to detect new Covid variants with the LFD?
"Just saying. The board was full of it. Then it didn't happen, any of it.
"It's all just so much talk and 'hot air' until it actually happens."
Anyone who is not aware of the four facts Eggy steamrollered to make this totally fabricated argument (FUD) should filter the account now or run the risk of being scared into selling through sheer ignorance.
1. Dx and Tx are completely different industries with different timescales, margins, regulatory control, etc, etc.
2. It was the antibody that failed, not the Affimer.
3. Given the time required to develop a new product and get approval to sell, the peak Covid opportunity was over.
4. No British companies could compete on cost and quantity with the cheap Chinese tests the Tory government was paying hand over fist to have imported, no matter the quality of the tests.
@5RINGS' "Something fishy is going on. Shareholders need to be let into the laboratories to see for themselves. I'm not convinced about the work going on here."
🤣🤣🤣🤣🤣
Probably the most idiotic comment I've ever read on here. Really this standard of FUD...🙄
@MelvinAFC, if AB is making up the financial stuff, what's the CFO doing? Why do you ascribe everything to AB, idiot.
No one should forget that HurstBot is permanently set to Moron.
Feb 28 RNS: "The Group continues to explore all available pathways to appropriately finance its clinical therapeutics programmes over the longer term, including non-dilutive funding through business development, attracting global specialist biotech investors and potentially a NASDAQ dual-listing. Avacta is also actively exploring routes to divest its Diagnostics division in a manner which maximises value for shareholders."
Ignoring the last sentence about divesting Dx without losing too much money on the adventure (see what AS did there?), the only option under Avacta's own control (apart from another giveaway fundraise) is the potential NASDAQ dual-listing that was thrown in there without any conviction. My experience of NASDAQ-listed companies is that they give full financial and business reports every quarter. That alone would be a good move for Avacta, if they dare expose themselves by publicly announcing the state of everything in quarterly updates.
How many of those shares do they own? - None
How much has it cost them? - Nothing
Does that represent confidence that the SP will go up? - No
Has AS got any credibility left? Investing a mere £10,000 for 20,000 shares doesn't exactly scream "This company is going to the moon!!!! And I'm going make a massive return on these shares!!!!!" does it.
Particularly no so when the CFO doesn't put his hand in his pocket to invest in ANY shares at all.
CFO definitely needs to go, CEO needs to pull a rabbit (a real live rabbit) out of the hat to avoid being voted out.